Cargando…
Genetically Modified T Cells for Esophageal Cancer Therapy: A Promising Clinical Application
Esophageal cancer is an exceedingly aggressive and malignant cancer that imposes a substantial burden on patients and their families. It is usually treated with surgery, chemotherapy, radiotherapy, and molecular-targeted therapy. Immunotherapy is a novel treatment modality for esophageal cancer wher...
Autores principales: | Zhu, Yu-Ge, Xiao, Bu-Fan, Zhang, Jing-Tao, Cui, Xin-Run, Lu, Zhe-Ming, Wu, Nan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630679/ https://www.ncbi.nlm.nih.gov/pubmed/34858843 http://dx.doi.org/10.3389/fonc.2021.763806 |
Ejemplares similares
-
Chimeric Antigen Receptor T-Cell Therapy in Lung Cancer: Potential and Challenges
por: Xiao, Bu-Fan, et al.
Publicado: (2021) -
Application of Data Science in Circulating Tumor DNA Detection: A Promising Avenue Towards Liquid Biopsy
por: Li, Ming, et al.
Publicado: (2021) -
The Application of Nimotuzumab Combined With Definitive Chemoradiotherapy Toward the Treatment of Locally Advanced Cervical Esophageal Carcinoma: A Retrospective Study
por: Hu, Jing, et al.
Publicado: (2022) -
Risk Factors and Genetic Biomarkers of Multiple Primary Cancers in Esophageal Cancer Patients
por: Yang, Pei-Wen, et al.
Publicado: (2021) -
Natural Products: A Promising Therapeutics for Targeting Tumor Angiogenesis
por: Li, Ruyi, et al.
Publicado: (2021)